» Articles » PMID: 26649298

PFOS Disturbs BDNF-ERK-CREB Signalling in Association with Increased MicroRNA-22 in SH-SY5Y Cells

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2015 Dec 10
PMID 26649298
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Perfluorooctane sulfonate (PFOS), a ubiquitous environmental pollutant, is neurotoxic to mammalian species. However, the underlying mechanism of its neurotoxicity was unclear. We hypothesized that PFOS suppresses BDNF expression to produce its neurotoxic effects by inhibiting the ERK-CREB pathway. SH-SY5Y human neuroblastoma cells were exposed to various concentrations of PFOS to examine the role of the BDNF-ERK-CREB signalling pathway in PFOS-induced apoptosis and cytotoxicity. Furthermore, to ascertain the mechanism by which PFOS reduces BDNF signalling, we examined the expression levels of miR-16 and miR-22, which potentially regulate BDNF mRNA translation at the posttranscriptional level. Results indicated that PFOS significantly decreased cell viability and induced apoptosis in SH-SY5Y cells. In addition, BDNF and pERK protein levels decreased after PFOS treatment; however, pCREB protein levels were significantly elevated in PFOS treated groups. TrkB protein expression increased in the 10 μM and 50 μM PFOS groups and significantly decreased in the 100 μM PFOS group. Our results demonstrated that PFOS exposure decreased miR-16 expression and increased miR-22 expression, which may represent a possible mechanism by which PFOS decreases BDNF protein levels. PFOS may inhibit BDNF-ERK-CREB signalling by increasing miR-22 levels, which may, in part, explain the mechanism of PFOS neurotoxicity.

Citing Articles

ZS09 Can Improve Antibiotic-Induced Motor Dysfunction in Mice by Regulating the Brain-Gut Functions.

Yang Y, Zhao Y, Lei H, Tan X J Inflamm Res. 2024; 17:10093-10106.

PMID: 39634287 PMC: 11616420. DOI: 10.2147/JIR.S486018.


Adverse outcome pathway for the neurotoxicity of Per- and polyfluoroalkyl substances: A systematic review.

Li S, Qin S, Zeng H, Chou W, Oudin A, Kanninen K Eco Environ Health. 2024; 3(4):476-493.

PMID: 39605965 PMC: 11599988. DOI: 10.1016/j.eehl.2024.08.002.


Therapeutic effects of tetrahedral framework nucleic acids and tFNAs-miR22 on retinal ischemia/reperfusion injury.

Xu X, Fu Y, Luo D, Zhang L, Huang X, Chen Y Cell Prolif. 2024; 57(11):e13695.

PMID: 39086110 PMC: 11533083. DOI: 10.1111/cpr.13695.


BDNF Modulation by microRNAs: An Update on the Evidence.

De Assis G, Murawska-Cialowicz E Cells. 2024; 13(10.

PMID: 38786102 PMC: 11119608. DOI: 10.3390/cells13100880.


Neuroprotective effect of ranolazine improves behavioral discrepancies in a rat model of scopolamine-induced dementia.

Samir S, Hassan H, Elmowafy R, ElNashar E, Alghamdi M, AlSheikh M Front Neurosci. 2024; 17:1267675.

PMID: 38323121 PMC: 10845649. DOI: 10.3389/fnins.2023.1267675.


References
1.
Renner R . Growing concern over perfluorinated chemicals. Environ Sci Technol. 2001; 35(7):154A-160A. DOI: 10.1021/es012317k. View

2.
Finkbeiner S, Tavazoie S, Maloratsky A, Jacobs K, Harris K, Greenberg M . CREB: a major mediator of neuronal neurotrophin responses. Neuron. 1997; 19(5):1031-47. DOI: 10.1016/s0896-6273(00)80395-5. View

3.
Hebert S, Sergeant N, Buee L . MicroRNAs and the Regulation of Tau Metabolism. Int J Alzheimers Dis. 2012; 2012:406561. PMC: 3374946. DOI: 10.1155/2012/406561. View

4.
Liu X, Liu W, Jin Y, Yu W, Liu L, Yu H . Effects of subchronic perfluorooctane sulfonate exposure of rats on calcium-dependent signaling molecules in the brain tissue. Arch Toxicol. 2010; 84(6):471-9. DOI: 10.1007/s00204-010-0517-9. View

5.
Long Y, Wang Y, Ji G, Yan L, Hu F, Gu A . Neurotoxicity of perfluorooctane sulfonate to hippocampal cells in adult mice. PLoS One. 2013; 8(1):e54176. PMC: 3559704. DOI: 10.1371/journal.pone.0054176. View